奧星生命科技(06118.HK)盈喜:預計中期純利2300萬至2500萬元
格隆匯7月31日丨奧星生命科技(06118.HK)發佈公吿,預期將錄得截至2025年6月30日止六個月公司擁有人應占溢利約人民幣2300萬元至2500萬元,而截至2024年6月30日止六個月公司擁有人應占溢利約為人民幣588萬元。
公吿表示,此顯著利潤增長主要源於:(i)集團對策略性增效措施的專注落實,具體體現在行政及研究與開發(“研發”)支出的優化;及(ii)其他收益增加,此增長主要來自截至2025年6月30日止六個月錄得的匯兑收益。
行政與研發支出的優化,源於集團在組織精簡化及卓越營運方面的主動舉措。這些措施不僅反映更嚴謹的資源配置,亦提升了財務靈活性,使集團能將資源重新導向戰略增長領域。相關舉措不僅彰顯短期盈利能力,更構建了創造長期價值的可持續發展模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.